Literature DB >> 2730567

Kinetic characteristics of a thioredoxin-activated rat hepatic and renal low-Km iodothyronine 5'-deiodinase.

G B Bhat1, K Iwase, B C Hummel, P G Walfish.   

Abstract

The properties and kinetic characteristics of a non-GSH NADPH-dependent cofactor system activating rat hepatic and renal 5'-deiodinase (5'-DI), which we have previously demonstrated with partially purified cytosol Fractions A and B [Sawada, Hummel & Walfish (1986) Biochem. J. 234, 391-398], were examined further. Although microsomal fractions prepared from either rat liver or kidneys could be activated by crude cytosol Fractions A and B from those tissues as well as from rat brain and heart, a homologous hepatic or renal system was the most potent in producing 5'-deiodination of reverse tri-iodothyronine (rT3). At nanomolar concentrations both rT3 and thyroxine (T4) were deiodinated but with a much greater substrate preference for rT3 than for T4. However, at micromolar concentrations of these substrates no activation of 5'-DI could be detected. In this deiodinative system, T4 and tri-iodothyronine (T3) competitively inhibited 5'-deiodination of rT3. Dicoumarol, iopanoate, arsenite and diamide were also inhibitory to the activation of hepatic or renal 5'-deiodination by this cofactor system. Purification of cofactor components in hepatic crude cytosolic Fractions A and B to near homogeneity, as assessed by their enzymic and physical properties, indicated that these co-purified with and were therefore identical with thioredoxin reductase and thioredoxin respectively, and accounted almost entirely for the observed activation of rT3 5'-DI. When highly purified liver cytosolic thioredoxin reductase and thioredoxin were utilized to determine the kinetic characteristics of the reaction, evidence for a sequential mechanism operative at nanomolar but not micromolar concentrations of rT3 and T4 was obtained. The Km for rT3 was 1.4 nM. Inhibition by 6-n-propyl-2-thiouracil (Ki 6.7 microM) was competitive with respect to thioredoxin and non-competitive with respect to rT3, whereas inhibition by T4 (Ki 1.3 microM) was competitive. Since rT3 is a potent inhibitor of T4 5'-deiodination, this thioredoxin system activating deiodination of rT3 may play an important role in regulating the rate of intracellular production of T3 from T4.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2730567      PMCID: PMC1138433          DOI: 10.1042/bj2580785

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  Subcellular localization of a rat liver enzyme converting thyroxine into tri-iodothyronine and possible involvement of essential thiol groups.

Authors:  T J Visser; I Does-Tobé; R Docter; G Hennemann
Journal:  Biochem J       Date:  1976-08-01       Impact factor: 3.857

2.  The kinetics of enzyme-catalyzed reactions with two or more substrates or products. I. Nomenclature and rate equations.

Authors:  W W CLELAND
Journal:  Biochim Biophys Acta       Date:  1963-01-08

Review 3.  Pathways of metabolism of thyroid hormones.

Authors:  I J Chopra; D H Solomon; U Chopra; S Y Wu; D A Fisher; Y Nakamura
Journal:  Recent Prog Horm Res       Date:  1978

4.  Isolation and characterization of calf liver thioredoxin.

Authors:  N E Engström; A Holmgren; A Larsson; S Söderhäll
Journal:  J Biol Chem       Date:  1974-01-10       Impact factor: 5.157

5.  A specific and sensitive assay for disulfides.

Authors:  W L Zahler; W W Cleland
Journal:  J Biol Chem       Date:  1968-02-25       Impact factor: 5.157

6.  Characterization of essential enzyme sulfhydryl groups of thyroxine 5'-deiodinase from rat kidney.

Authors:  J L Leonard; I N Rosenberg
Journal:  Endocrinology       Date:  1980-02       Impact factor: 4.736

7.  Iodothyronine 5'-deiodinase from rat kidney: substrate specificity and the 5'-deiodination of reverse triiodothyronine.

Authors:  J L Leonard; I N Rosenberg
Journal:  Endocrinology       Date:  1980-11       Impact factor: 4.736

8.  A tentative review of recent in vitro observations of the enzymatic deiodination of iodothyronines and its possible physiological implications.

Authors:  T J Visser
Journal:  Mol Cell Endocrinol       Date:  1978-05       Impact factor: 4.102

9.  Thyroxine 5'-deiodinase activity of rat kidney: observations on activation by thiols and inhibition by propylthiouracil.

Authors:  J L Leonard; I N Rosenberg
Journal:  Endocrinology       Date:  1978-12       Impact factor: 4.736

10.  Mechanism of action of iodothyronine-5'-deiodinase.

Authors:  T J Visser
Journal:  Biochim Biophys Acta       Date:  1979-08-15
View more
  5 in total

1.  NADPH-dependent reductive ortho dehalogenation of 2,4-dichlorobenzoic acid in Corynebacterium sepedonicum KZ-4 and Coryneform bacterium strainNTB-1 via 2,4-dichlorobenzoyl coenzyme A.

Authors:  V Romanov; R P Hausinger
Journal:  J Bacteriol       Date:  1996-05       Impact factor: 3.490

2.  Insights into the Mechanism of Human Deiodinase 1.

Authors:  Alfonso Rodriguez-Ruiz; Doreen Braun; Simon Pflug; Alexander Brol; Marc Sylvester; Clemens Steegborn; Ulrich Schweizer
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

3.  Substitution of serine for proline in the active center of type 2 iodothyronine deiodinase substantially alters its in vitro biochemical properties with dithiothreitol but not its function in intact cells.

Authors:  Iuri Martin Goemann; Balázs Gereben; John W Harney; Bo Zhu; Ana Luiza Maia; P Reed Larsen
Journal:  Endocrinology       Date:  2009-12-04       Impact factor: 4.736

4.  Crystal structure of mammalian selenocysteine-dependent iodothyronine deiodinase suggests a peroxiredoxin-like catalytic mechanism.

Authors:  Ulrich Schweizer; Christine Schlicker; Doreen Braun; Josef Köhrle; Clemens Steegborn
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-07       Impact factor: 11.205

5.  Toward a chemical marker for inflammatory disease: a fluorescent probe for membrane-localized thioredoxin.

Authors:  Min Hee Lee; Hyun Mi Jeon; Ji Hye Han; Nayoung Park; Chulhun Kang; Jonathan L Sessler; Jong Seung Kim
Journal:  J Am Chem Soc       Date:  2014-05-28       Impact factor: 15.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.